胰島素輸注裝置市場規模、佔有率和成長分析（按產品類型、糖尿病類型、最終用戶和地區分類）－2026-2033年產業預測

全球胰島素輸送設備市場規模預計在 2024 年達到 180.2 億美元，從 2025 年的 194.4 億美元成長到 2033 年的 357.2 億美元，在預測期（2026-2033 年）內複合年成長率為 7.9%。

全球胰島素輸注設備市場正經歷強勁成長，主要驅動力是全球糖尿病患者數量的不斷增加。這種需求的激增推動了更先進、更便利的糖尿病管理系統的發展。數位技術的整合有望進一步促進市場擴張，尤其是透過持續血糖監測（CGM）系統等創新技術。 CGM系統使胰島素輸注設備能夠根據持續的血糖值測量值即時自動調整劑量。此外，穿戴式式和貼片式胰島素幫浦因其隱蔽性和便利性而備受關注。包括貼片式胰島素系統極具前景的新應用在內的技術進步，代表著胰島素輸注方式在滿足患者需求方面的能力和有效性的顯著提升。

推動全球胰島素輸注設備市場發展的因素

全球胰島素輸注設備市場正經歷顯著成長，這得益於一個可互通生態系統的興起，該生態系統將胰島素輸注系統與持續血糖監測儀 (CGM)、智慧型手機應用程式、智慧胰島素筆和連網胰島素幫浦整合在一起。這種互聯互通提高了給藥精度，增強了患者的依從性，並支持醫護人員進行遠端監測，從而減少了低血糖事件和就診次數。隨著遠距遠端醫療服務和數位化糖尿病管理計畫的報銷範圍不斷擴大，越來越多的連網設備被應用於居家照護和門診治療。這一趨勢不僅增強了醫護人員的信心，也提高了病患的舒適度和糖尿病管理的參與度。

全球胰島素輸送裝置市場限制因素

全球胰島素輸注設備市場，尤其是自動胰島素幫浦和整合系統市場，面臨設備及其耗材高成本的巨大挑戰，這在價格敏感的市場中構成了一大障礙。地區報銷政策的差異進一步加劇了這一困境，而有限的保險覆蓋範圍也往往降低了產品的普及率。此外，許多支付方不願核准貼片幫浦和閉合迴路系統等先進技術，阻礙了市場滲透。為了改善病患用藥途徑並降低成本，製造商必須證明其產品在醫療環境中的合法性和可行性。

全球胰島素輸注裝置市場趨勢

緊湊型無導管貼片式胰島素幫浦的普及是全球胰島素輸注設備市場的一大趨勢，它將胰島素注射轉變為更便利、更人性化的體驗。這些創新設備摒棄了繁瑣的導管，同時整合了先進的智慧型手機控制和自動化演算法，從而提升了用戶的舒適度和依從性。這項技術革新不僅吸引了現有用戶，也吸引了那些對傳統胰島素幫浦猶豫不決的患者。隨著醫療專業人員不斷評估並推薦這些系統，以期改善患者的治療效果，預計此類設備的需求將大幅成長，這反映出人們正朝著更高效的糖尿病管理解決方案轉變。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管環境

全球胰島素輸注裝置市場規模（依產品類型及複合年成長率分類）（2026-2033 年）

• 胰島素筆
• 胰島素幫浦（有線）
• 胰島素幫浦（無導管/貼片式）
• 胰島素注射器和針頭
• 智慧型胰島素輸送裝置

全球胰島素輸注裝置市場規模（依糖尿病類型分類）及複合年成長率（2026-2033 年）

• 1型糖尿病
• 2型糖尿病
• 妊娠糖尿病
• 其他特殊患者群

全球胰島素輸注設備市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 居家照護/自我管理
• 醫院和診所
• 專業糖尿病照護中心

全球胰島素注射裝置市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Medtronic plc
• Insulet Corporation
• Novo Nordisk A/S
• Sanofi
• Eli Lilly and Company
• Ypsomed AG
• B. Braun SE
• Owen Mumford Ltd.
• BD（Becton, Dickinson and Company）
• Tandem Diabetes Care, Inc.
• Roche Holding AG（Diabetes Care Division）
• Abbott Laboratories（Diabetes Care）
• Johnson & Johnson（Diabetes Solutions）
• Dexcom, Inc.（Integrated pump solutions）
• Ascensia Diabetes Care Holdings AG
• SOOIL Development Co., Ltd.
• Nippon Boehringer Ingelheim Co., Ltd.
• Terumo Corporation
• AgaMatrix
• Omron Healthcare Co., Ltd.

結論與建議

Global Insulin Delivery Devices Market size was valued at USD 18.02 Billion in 2024 and is poised to grow from USD 19.44 Billion in 2025 to USD 35.72 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The global market for insulin delivery devices is experiencing robust growth, primarily fueled by the rising prevalence of diabetes worldwide. This surge in demand is leading to the development of more advanced, user-friendly diabetes management systems. The integration of digital technologies is expected to further propel market expansion, particularly through innovations like Continuous Glucose Monitoring (CGM) systems, which enable insulin delivery devices to automatically adjust dosages in real-time based on continuous glucose readings. Additionally, wearable and patch insulin pumps are gaining traction as discreet and convenient solutions for insulin administration. The advancement of technologies, including promising new applications for patch insulin systems, signifies a significant evolution in the capabilities and effectiveness of insulin delivery methods, catering to the needs of patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Delivery Devices Market Segments Analysis

Global Insulin Delivery Devices Market is segmented by Product Type, Diabetes Type, End-User and region. Based on Product Type, the market is segmented into Insulin Pens, Insulin Pumps (Tethered), Insulin Pumps (Tubeless / Patch), Insulin Syringes & Needles and Smart Insulin Delivery Devices. Based on Diabetes Type, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes and Other Special Populations. Based on End-User, the market is segmented into Home Care / Self-administration, Hospitals & Clinics and Specialized Diabetes Care Centres. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Delivery Devices Market

The Global Insulin Delivery Devices market is experiencing significant growth due to the rise of interoperable ecosystems that integrate insulin delivery systems with continuous glucose monitors (CGMs), smartphone applications, smart pens, and connected pumps. This connectivity enhances dosage precision, fosters patient adherence, and enables remote monitoring by healthcare providers, which can lead to a reduction in hypoglycemic events and decreased hospital visits. As reimbursement for telehealth services and digital diabetes management programs continues to expand, more connected devices are being introduced into home care and outpatient settings. This trend not only boosts clinician confidence but also increases patient comfort and engagement in their diabetes management.

Restraints in the Global Insulin Delivery Devices Market

The Global Insulin Delivery Devices market faces significant challenges due to the elevated costs associated with these devices and their necessary consumables, especially for automated pumps and integrated systems, which creates barriers for price-sensitive markets. Variations in reimbursement mechanisms across regions further complicate the situation, often leading to decreased adoption when coverage is limited. Moreover, many payers exhibit hesitance in endorsing advanced technologies such as patch pumps and closed-loop systems, which hinders their market penetration. To enhance accessibility and reduce expenses for patients, manufacturers must demonstrate that their products are justifiable and attainable within the healthcare landscape.

Market Trends of the Global Insulin Delivery Devices Market

The Global Insulin Delivery Devices market is witnessing a notable trend towards the adoption of smaller, tubeless patch pumps, which are transforming insulin administration into a more convenient and user-friendly experience. These innovative devices are designed to enhance user comfort and compliance by eliminating cumbersome tubing while integrating advanced smartphone controls and automated algorithms. This technological evolution is appealing not only to existing users but also to those who have been hesitant to embrace traditional insulin pumps. As healthcare professionals continue to endorse these systems for their potential to improve patient outcomes, the demand for such devices is anticipated to surge, reflecting a broader shift towards more efficient diabetes management solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Insulin Delivery Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Insulin Pens
• Insulin Pumps (Tethered)
• Insulin Pumps (Tubeless / Patch)
• Insulin Syringes & Needles
• Smart Insulin Delivery Devices

Global Insulin Delivery Devices Market Size by Diabetes Type & CAGR (2026-2033)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Other Special Populations

Global Insulin Delivery Devices Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Home Care / Self-administration
• Hospitals & Clinics
• Specialized Diabetes Care Centres

Global Insulin Delivery Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Diabetes Type, End-User)
  • US
  • Canada
• Europe (Product Type, Diabetes Type, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Diabetes Type, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Diabetes Type, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Diabetes Type, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Diabetes Care Division)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (Diabetes Care)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (Diabetes Solutions)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (Integrated pump solutions)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SOOIL Development Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nippon Boehringer Ingelheim Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omron Healthcare Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations